Bill Snyder Archive — Page 32 of 121
-
October 10, 2022
Counting steps can reduce disease risk: study
A Vanderbilt study found that using a wearable activity tracker to count and increase the number and intensity of steps taken daily can reduce the risk of several common, chronic diseases. -
October 10, 2022
Opening a window to glaucoma
A metalloprotease enzyme plays an important role in retinal ganglion cell development, Vanderbilt researchers discovered; studying it and other family members may lead to the identification of novel targets for treating glaucoma. -
October 6, 2022
Vanderbilt’s Crowe receives the Building the Foundation Award from Research!America
Vanderbilt's James Crowe Jr., MD, has received the Building the Foundation Award from Research!America, a national biomedical research advocacy organization. -
October 6, 2022
VUMC to test whether Alzheimer’s drug can ease lupus symptoms
Vanderbilt University Medical Center is partnering with Evergreen Therapeutics Inc. to test whether an Alzheimer’s drug, memantine, can improve cognitive symptoms associated with systemic lupus. -
October 4, 2022
Vanderbilt’s Terker wins NIH Director’s Early Independence Award
Andrew Terker, MD, PhD, a physician-scientist at Vanderbilt University Medical Center who is committed to advancing the understanding and treatment of kidney disease, has received a 2022 National Institutes of Health Director’s Early Independence Award. -
September 29, 2022
VUMC lands grant to build top-line biosafety facility
Vanderbilt University Medical Center is set to construct a state-of-the-art BioSafety Level 3 (BSL3) facility for research involving the COVID-19 virus, anthrax and other dangerous microorganisms.